
Pharma Business - February 2, 2015
Profits for Novo Nordisk in 2014
Novo Nordisk increased operating profit in local currencies by 13 percent and by 10 percent in Danish kroner to DKK 34.5 billion in 2014. Sales growth of 8 percent in local currencies was driven by increased sales of Levemir® and Victoza®. Sales also increased by 6 percent in Danish kroner to 88.8 billion. Gross margin improved […]

Uncategorized - December 17, 2014
R&D Profits Increase for Swedish Companies
The profits of Swedish pharmaceutical companies linked to research and development, (R&D) this year landed at 5.5 percent, an increase from 5.1 percent last year and it is the first time there was an increase since 2010. This is according to a new study in which the 12 largest life science companies ‘ spending on […]